Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-30 @ 4:32 PM
Study NCT ID:
NCT00276861
Status:
TERMINATED
Last Update Posted:
2017-02-08
First Post:
2006-01-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Sponsor:
University of Miami
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20030655
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None